Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Jiaying Lai Technology is a biotechnology company headquartered in Chengdu, China, focused on the development of soluble microneedle drug delivery systems. The company utilizes a proprietary platform to create transdermal patches that deliver therapeutic agents painlessly and efficiently, bypassing the need for traditional needle injections. Their technology is applicable across several sectors, including chronic disease management, vaccine delivery, and medical aesthetics. Jiaying Lai's pipeline includes innovative treatments for diabetes and various dermatological applications. By improving drug stability and patient adherence, the company seeks to transform the delivery of biologics and small molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Jiaying Lai Technology.